Difficulty: Medium
Average Score: 92%
Practice
A 54-year-old woman with a history of migraine headaches has begun on therapy with Topamax as prophylaxis. She is poorly communicative and a poor historian. Which of the following would be important coexisting conditions to know about?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Kidney stones. When a patient is prescribed Topamax for migraine prophylaxis, it's crucial to be aware of any coexisting conditions that could be impacted by the medication. Topamax is known to increase the risk of kidney stone formation in patients. Therefore, knowing if the patient has a history of kidney stones is vital for monitoring and managing this potential side effect.
Option A) Depression, while a valid concern, is not directly related to the pharmacological effects of Topamax in this context. Option C) Nearsightedness and Option D) Pulmonary deficits are also unrelated to the medication and the patient's condition.
Educationally, this question highlights the importance of considering potential side effects and interactions of medications in patients with specific health conditions. Understanding the significance of patient history in guiding pharmacological therapy is essential for safe and effective care. This rationale emphasizes the need for thorough assessment and consideration of individual patient factors in pharmacological management across the lifespan.
Option A) Depression, while a valid concern, is not directly related to the pharmacological effects of Topamax in this context. Option C) Nearsightedness and Option D) Pulmonary deficits are also unrelated to the medication and the patient's condition.
Educationally, this question highlights the importance of considering potential side effects and interactions of medications in patients with specific health conditions. Understanding the significance of patient history in guiding pharmacological therapy is essential for safe and effective care. This rationale emphasizes the need for thorough assessment and consideration of individual patient factors in pharmacological management across the lifespan.